Related Experiment Video

Updated: Jul 4, 2026

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
04:56

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Published on: August 4, 2023

Protein composition of plasminogen activator inhibitor type 1-derived endothelial microparticles

Tara L Sander1, Jing-Song Ou, John C Densmore

  • 1Department of Surgery, Medical College of Wisconsin and Children's Research Institute, Milwaukee, WIsconsin 53226, USA.

Shock (Augusta, Ga.)
|July 4, 2008
PubMed

Insights

Researchers identified 58 proteins in endothelial microparticles (EMPs) from human cells stimulated with PAI-1. This study offers new insights into the diverse protein composition and generation of these important cell-derived vesicles.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Proteomics

Background:

  • Endothelial microparticles (EMPs) are vesicles released from endothelial cells during injury, apoptosis, or activation.
  • Elevated EMP levels are observed in certain pathological conditions, but their formation and effects are not fully understood.
  • Understanding EMP protein composition is crucial for elucidating their biological roles.

Purpose of the Study:

  • To determine the protein composition of EMPs derived from human umbilical cord endothelial cells.
  • To investigate the effect of plasminogen activator inhibitor type 1 (PAI-1) stimulation on EMP protein content.
  • To gain insight into the generation mechanisms and functional diversity of PAI-1-stimulated EMPs.

Main Methods:

  • Human umbilical cord endothelial cells were stimulated with PAI-1.
  • Proteins from derived EMPs were analyzed using two-dimensional gel electrophoresis and mass spectrometry.
  • Identified proteins were further validated by Western blot analysis and functionally annotated using Gene Ontology.

Main Results:

  • A total of 58 proteins were identified in PAI-1-stimulated EMPs.
  • Proteins originated from diverse cellular components and exhibited a wide range of molecular functions.
  • Analysis revealed involvement in various biological processes, highlighting the complexity of EMP cargo.

Conclusions:

  • PAI-1 stimulation leads to the release of EMPs with a highly diverse protein composition.
  • These EMPs contain proteins involved in multiple cellular functions and biological pathways.
  • The findings provide significant insight into the generation and molecular makeup of PAI-1-derived EMPs.

More Related Videos

Affinity Purification of a Fibrinolytic Enzyme from Sipunculus nudus06:45

Affinity Purification of a Fibrinolytic Enzyme from Sipunculus nudus

Published on: June 2, 2023

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment10:59

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment

Published on: November 23, 2017

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Composition of Blood Plasma01:24

Composition of Blood Plasma

Blood plasma is a fluid that contains approximately 92% water and 8% solutes. The solutes include various types of proteins, which constitute about 7% of the total solutes in the plasma. The high-molecular-weight proteins—albumins, globulins, and fibrinogen—are essential to plasma function. Albumins, making up about 60% of the plasma proteins, maintain the osmotic balance within blood vessels by preventing excessive water leakage. Additionally, albumins serve as carrier proteins, binding to...